Utilizing Expertise & Experience for Successful Downstream Processing

Technical proficiency in downstream processes is critical for successful drug substance manufacturing. Utilizing a CDMO’s experience and expertise in developing appropriate processes for your molecule can help achieve program goals.

Evolution of Lipid-based Formulation Manufacturing

Lipid-based formulations are gaining global awareness, notably with lipid nanoparticles (LNPs) being a key component in several current COVID-19 and mRNA vaccines. Lipid-based formulations, including liposomes and LNPs, are an effective drug delivery system for a variety of active pharmaceutical ingredients (APIs), notably for complex parenteral drug products including cancer, viral, and gene therapeutics. In this podcast, we discuss how Emergent has been involved in the manufacturing of lipid-based formulations over the past two decades, along with factors to consider when partnering with a CDMO for lipid-based formulation manufacturing.